Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.02 USD | +0.17% | -10.28% | +2.38% |
Feb. 27 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.33M | Capitalization | 576M |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -232M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 434 x |
P/E ratio 2024 * |
-3.01
x | P/E ratio 2025 * |
-3.02
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.68% |
Latest transcript on Cogent Biosciences, Inc.
1 day | +0.17% | ||
1 week | -10.28% | ||
Current month | -10.42% | ||
1 month | -10.42% | ||
3 months | +37.60% | ||
6 months | -26.85% | ||
Current year | +2.38% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 237 M€ | +2.89% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.02 | +0.17% | 912,165 |
24-04-25 | 6.01 | -8.10% | 1,212,019 |
24-04-24 | 6.54 | -6.03% | 1,775,037 |
24-04-23 | 6.96 | -2.25% | 1,209,832 |
24-04-22 | 7.12 | +6.11% | 891,876 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.38% | 576M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- COGT Stock